(4R,5R)-5-((R)-1,2-Dihydroxyethyl)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde

Catalog No. :
ACRFBJ172
CAS No. :
13199-25-2
Molecular Formula :
C8H14O5
Molecular Weight :
190.20

IUPAC Name:(4R,5R)-5-((R)-1,2-dihydroxyethyl)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde

(4R,5R)-5-((R)-1,2-Dihydroxyethyl)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$55.00Login to see priceInquiryInquiry
5g95%$188.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4R,5R)-5-((R)-1,2-Dihydroxyethyl)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde
IUPAC Name(4R,5R)-5-((R)-1,2-dihydroxyethyl)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde
MDL No.MFCD02094261
Molecular FormulaC8H14O5
Molecular Weight190.20
SMILESO=C[C@@H]1OC(C)(C)O[C@@H]1[C@H](O)CO
InChI KeyQQMGPCNMYKBXNC-DSYKOEDSSA-N
Synonym2,3-O-ISOPROPYLIDENE-D-RIBOFURANOSE;2,3-O-ISOPROPYLIDENE-ALPHA,BETA-D-RIBOFURANOSE;2,3-O-ISOPROPYLIDENE-ALPHA,SS-D-RIBOFURANOSE;2,3-O-ISOPROPYLIDENE-A,B-D-RIBOFURANOSE;2,3-O-Isopropylidene-D-ribofuranoside;2,3-O-Isopropylidene-D-ribose;2,3Isopropylidene-alpha,~-D-ribofuranose;2,3-O-Isopropylidene-alpha,-D-ribofuranose
CAS No.13199-25-2
PubChem CID18639771

Synthetic Route by SureRoute

1. ACRFBJ172 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXQJF351 route compound structure diagram
    ACXQJF35150-69-1 In Stock
  4. Then
  5. ACRFBJ172 route product structure diagram
    ACRFBJ17213199-25-2
Inquiry

2. ACRFBJ172 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXQJF351 route compound structure diagram
    ACXQJF35150-69-1 In Stock
  4. Then
  5. ACRFBJ172 route product structure diagram
    ACRFBJ17213199-25-2
Inquiry

Comments (0)